Pharmally Scandal Probe | Gordon on Senate Blue Ribbon Corruption Case

In this investigative political discussion, Richard Gordon breaks down key developments in the Philippine Senate Blue Ribbon Committee hearings, focusing on the Pharmally controversy and wider corruption allegations involving large-scale public fund movements.

Gordon examines questions surrounding accountability mechanisms, including the role of anti-money laundering oversight through the Anti-Money Laundering Council and transaction monitoring by state financial institutions such as Land Bank of the Philippines. He raises concerns about how billions in government disbursements were processed and whether proper safeguards were enforced.

The discussion also highlights Senate investigative authority, subpoena powers, and the importance of sworn testimony in uncovering systemic corruption. Gordon critiques institutional weaknesses that, in his view, undermine public trust in governance and delay accountability.

Beyond the specific case, the interview explores broader political tensions, including Senate leadership dynamics, impeachment-related disputes, and ongoing debates about transparency, economic confidence, and institutional reform in the Philippines.